Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

DHR

Danaher Corp

Dec 13 • 04:00PM ET

234.89

Dollar change +0.39
Percentage change 0.17	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: GE HON MMM ROK KEYS ABT TMO MTD BSX

| Held by: VTI VOO SPY IVV VTV XLV VIG VHT IWD IVE

Scroll to Statements

Index	S&P 500	P/E	44.80	EPS (ttm)	5.24	Insider Own	4.06%	Shs Outstand	722.20M	Perf Week	2.07%
Market Cap	169.94B	Forward P/E	28.10	EPS next Y	8.36	Insider Trans	-0.30%	Shs Float	692.96M	Perf Month	-2.75%
Income	3.89B	PEG	6.22	EPS next Q	2.14	Inst Own	80.59%	Short Float	0.78%	Perf Quarter	-14.90%
Sales	23.74B	P/S	7.16	EPS this Y	-1.20%	Inst Trans	-1.84%	Short Ratio	1.95	Perf Half Y	-7.83%
Book/sh	71.03	P/B	3.31	EPS next Y	11.61%	ROA	4.67%	Short Interest	5.42M	Perf Year	3.54%
Cash/sh	3.63	P/C	64.69	EPS next 5Y	7.20%	ROE	7.59%	52W Range	219.15 - 281.70	Perf YTD	1.53%
Dividend Est.	0.99 (0.42%)	P/FCF	33.92	EPS past 5Y	11.31%	ROI	5.76%	52W High	-16.62%	Beta	0.83
Dividend TTM	1.05 (0.45%)	Quick Ratio	1.01	Sales past 5Y	8.35%	Gross Margin	59.37%	52W Low	7.18%	ATR (14)	4.58
Dividend Ex-Date	Dec 27, 2024	Current Ratio	1.37	EPS Y/Y TTM	-34.04%	Oper. Margin	20.44%	RSI (14)	43.45	Volatility	1.74% 1.86%
Employees	63000	Debt/Eq	0.37	Sales Y/Y TTM	-19.70%	Profit Margin	16.39%	Recom	1.50	Target Price	289.04
Option/Short	Yes / Yes	LT Debt/Eq	0.32	EPS Q/Q	-25.91%	Payout	16.45%	Rel Volume	0.87	Prev Close	234.50
Sales Surprise	3.78%	EPS Surprise	9.02%	Sales Q/Q	-15.64%	Earnings	Oct 22 BMO	Avg Volume	2.78M	Price	234.89
SMA20	-0.04%	SMA50	-5.11%	SMA200	-8.07%	Trades		Volume	2,411,232	Change	0.17%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-24	Upgrade	BofA Securities	Neutral → Buy	$290
Oct-31-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$285
Oct-01-24	Initiated	Stephens	Overweight	$315
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$280
Jun-03-24	Resumed	Jefferies	Buy	$295
Apr-17-24	Upgrade	HSBC Securities	Hold → Buy	$280
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight	$240
Dec-18-23	Initiated	HSBC Securities	Hold
Dec-13-23	Resumed	Wolfe Research	Peer Perform
Dec-07-23	Downgrade	Goldman	Buy → Neutral	$215 → $205
Jul-19-23	Initiated	Raymond James	Outperform	$270
May-01-23	Initiated	SVB Securities	Outperform	$300
Apr-26-23	Downgrade	BofA Securities	Buy → Neutral	$310 → $250
Apr-18-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $285
Jan-05-23	Downgrade	Credit Suisse	Outperform → Neutral	$315 → $300
Dec-14-22	Initiated	Deutsche Bank	Buy	$310
Oct-24-22	Downgrade	The Benchmark Company	Buy → Hold	$325
Aug-25-22	Initiated	Credit Suisse	Outperform	$340
Aug-17-22	Resumed	Bernstein	Outperform	$330 → $340
Jul-20-22	Initiated	UBS	Buy	$297

Show Previous Ratings

Today 02:04PM	Why Danaher Corporation (DHR) Is the Best Stock to Buy for the Long-Term According to Charles Akre? (Insider Monkey)
Dec-13-24 01:57PM	Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst (Benzinga)
Dec-12-24 06:02AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Dec-11-24 09:09AM	Heres Why Parnassus Growth Equity Fund Sold Danaher Corp. (DHR) (Insider Monkey)
Dec-10-24 04:15PM	Danaher Announces Quarterly Dividend (PR Newswire)
06:00AM	Loading…
Nov-29-24 06:00AM	Navigating Market Uncertainty: Intrinsic Value of Danaher Corp (GuruFocus.com)
Nov-26-24 05:00PM	Danaher to Present at Evercore ISI HealthCONx Conference (PR Newswire)
Nov-22-24 02:28PM	Danaher Corp (NYSE:DHR): A Bullish Investment Perspective (Insider Monkey)
Nov-20-24 02:34PM	Analyst Report: Danaher Corporation (Morningstar Research)
Nov-19-24 09:59AM	Danaher Corporation (DHR) Highlighted Milestones in its 2024 Corporate Sustainability Report (Insider Monkey)
Nov-15-24 07:37PM	Analyst Report: Danaher Corporation (Morningstar Research)
Nov-14-24 06:00AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
Nov-01-24 09:26AM	Heres Why Baron Health Care Fund Added Danaher Corporation (DHR) to its Portfolio (Insider Monkey)
Oct-31-24 08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Oct-28-24 09:15AM	Danaher (DHR) Reliance on International Sales: What Investors Need to Know (Zacks)
06:15AM	Loading…
Oct-26-24 06:15AM	Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks. (Motley Fool)
Oct-24-24 08:41AM	Danaher price target raised to $265 from $250 at Stifel (TipRanks)
Oct-23-24 04:25PM	Analyst Report: Danaher Corporation (Morningstar Research)
03:02AM	Danaher Corp (DHR) Q3 2024 Earnings Call Highlights: Resilient Performance Amidst Market Challenges (GuruFocus.com)
01:03AM	Decoding Danaher Corp (DHR): A Strategic SWOT Insight (GuruFocus.com)
12:21AM	Q3 2024 Danaher Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-22-24 05:25PM	Analyst Report: Danaher Corporation (Morningstar Research)
05:10PM	Jim Cramer on Danaher Corporation (DHR): Its A Very Important Position (Insider Monkey)
03:27PM	Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating (Benzinga)
09:30AM	Danaher (DHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:02AM	Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance (Benzinga)
07:10AM	Danaher (DHR) Tops Q3 Earnings and Revenue Estimates (Zacks)
06:07AM	Danaher: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Danaher Reports Third Quarter 2024 Results (PR Newswire)
Oct-17-24 10:21AM	Cramer's Mad Dash: Danaher (CNBC TV)
09:15AM	Loading…
09:15AM	Exploring Analyst Estimates for Danaher (DHR) Q3 Earnings, Beyond Revenue and EPS (Zacks)
Oct-16-24 08:00AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)
Oct-04-24 01:10PM	Is Danaher Corporation (NYSE:DHR) The Top Goldman Sachs Fund Manager Stock Pick? (Insider Monkey)
Oct-02-24 08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Sep-30-24 04:50AM	Cepheid Drives Danaher Corporation (DHR) Q2 2024 Success, Hedge Funds Rally Around the Stock (Insider Monkey)
Sep-27-24 02:53AM	Danaher Corporation (DHR): Why Are Billionaires Bullish on This Stock Right Now? (Insider Monkey)
Sep-19-24 04:30PM	Danaher Schedules Third Quarter 2024 Earnings Conference Call (PR Newswire)
Sep-18-24 08:00AM	Invest with Confidence: Intrinsic Value Unveiled of Danaher Corp (GuruFocus.com)
Sep-17-24 08:30AM	Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership (PR Newswire)
Sep-10-24 04:15PM	Danaher Announces Quarterly Dividend (PR Newswire)
Sep-04-24 04:30PM	Danaher Confirms Third Quarter and Full Year 2024 Guidance (PR Newswire)
08:00AM	Navigating Market Uncertainty: Intrinsic Value of Danaher Corp (GuruFocus.com)
Sep-03-24 11:32PM	Is Danaher Corporation (DHR) the Best Cancer Stock to Buy Now? (Insider Monkey)
Aug-26-24 05:30PM	Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C. (PR Newswire)
Aug-22-24 11:30AM	Why Is Danaher (DHR) Up 2% Since Last Earnings Report? (Zacks)
Aug-21-24 08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Aug-19-24 08:00AM	Genedata Announces It Is Joining Forces with Danaher Corporation (PR Newswire)
Aug-16-24 11:28AM	Danaher (DHR) Benefits From Business Strength Amid Risks (Zacks)
Aug-07-24 08:00AM	Unlocking Intrinsic Value: Analysis of Danaher Corp (GuruFocus.com)
05:30AM	Is Danaher Corporation (NYSE:DHR) the Best Undervalued Stock to Buy According to Jim Cramer? (Insider Monkey)
Aug-02-24 07:01PM	Insider Sale: Director Linda Filler Sells Shares of Danaher Corp (DHR) (GuruFocus.com)
Jul-30-24 07:30AM	Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimers Disease (GlobeNewswire)
Jul-26-24 11:41PM	Insider Sale: Senior Vice President - General Counsel Brian Ellis Sells 9,600 Shares of Danaher ... (GuruFocus.com)
05:46PM	Danaher Corporation (DHR): Hedge Funds Are Bullish on This Scientific Instruments Stock Right Now (Insider Monkey)
Jul-25-24 02:28PM	Final Trades: Freeport-McMoran, Pfizer, Danaher and United Rentals (CNBC TV)
09:00AM	Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration (PR Newswire)
Jul-24-24 08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
01:31AM	Q2 2024 Danaher Corp Earnings Call (Thomson Reuters StreetEvents)
01:01AM	Decoding Danaher Corp (DHR): A Strategic SWOT Insight (GuruFocus.com)
Jul-23-24 06:33PM	Why GE Stock Has Finally Recovered from the Great Recession (Investopedia) +5.30%
04:25PM	Medical Giant Danaher Nears Breakout On This 'Stark Contrast' With A Key Rival (Investor's Business Daily)
12:22PM	Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y (Zacks)
12:21PM	Analyst Report: Danaher Corporation (Morningstar Research)
12:00PM	Danaher Stock Soars on Q2 Earnings Beat (Investopedia)
11:50AM	Here's Why Danaher Stock Surged Today (Motley Fool)
10:57AM	Danaher Stock Is Surging. Strong Earnings Renew Hopes for Recovery. (Barrons.com)
09:59AM	Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance (Benzinga)
09:30AM	Here's What Key Metrics Tell Us About Danaher (DHR) Q2 Earnings (Zacks)
08:39AM	Danaher Stock Surges. More Than Earnings Are Driving It Higher. (Barrons.com)
07:10AM	Danaher (DHR) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:07AM	Danaher: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Danaher Reports Second Quarter 2024 Results (PR Newswire)
Jul-19-24 12:10PM	Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-18-24 10:19AM	Danaher (DHR) Gears Up to Post Q2 Earnings: What to Expect (Zacks)
05:44AM	Danaher setting up labs to support companion diagnostic development (MedTech Dive)
Jul-17-24 07:30AM	Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development (PR Newswire)
Jul-16-24 12:00PM	Danaher (DHR) Upgraded to Buy: Here's What You Should Know (Zacks)
09:40AM	Is Danaher (DHR) Stock Outpacing Its Conglomerates Peers This Year? (Zacks)
07:30AM	Danaher Releases 2024 Sustainability Report (PR Newswire)
Jul-13-24 05:56PM	Why Is Danaher Corporation (DHR) a Good Industrial Stock to Buy Now? (Insider Monkey)
03:29PM	10 Best Industrial Stocks to Buy According to Hedge Funds (Insider Monkey)
Jul-11-24 07:50AM	Here's Why Aristotle Capital's Value Equity Strategy Decided to Sell Veralto Corporation (VLTO) (Insider Monkey)
07:30AM	Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening (PR Newswire)
Jul-10-24 08:43AM	Here's Why L1 Capital International Fund Divested its Holdings in Danaher Corporation (DHR) (Insider Monkey)
08:00AM	Danaher Corp: An Exploration into Its Intrinsic Value (GuruFocus.com)
Jul-09-24 03:00AM	Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer (PR Newswire)
Jul-05-24 06:48AM	Is Lantheus Holdings Inc (NASDAQ:LNTH) the Best Jim Cramer Stock in 2024? (Insider Monkey)
Jul-04-24 07:47AM	Jim Cramer's Latest Stock Portfolio: Top 10 Recommendations (Insider Monkey)
Jun-26-24 08:00AM	The Art of Valuation: Discovering Danaher Corp's Intrinsic Value (GuruFocus.com)
Jun-24-24 04:30PM	Danaher Schedules Second Quarter 2024 Earnings Conference Call (PR Newswire)
10:24AM	Did Danaher Corporation (DHR) Get a Good Analyst Rating for Its Q1 Performance? (Insider Monkey)
Jun-19-24 07:30AM	Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics (PR Newswire)
Jun-17-24 09:27AM	RGIA: Danaher Corporation (DHR): Purity in the Crown Jewel of Bioprocessing (Insider Monkey)
Jun-14-24 10:00AM	Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now (Zacks)
07:26AM	3 CEOs Who Could Steer Boeing Back to Clear Skies (InvestorPlace)
Jun-13-24 05:35AM	Pall Corporation opens regional hub in Singapore (Investment Monitor)
Jun-12-24 08:00AM	Beyond Market Price: Uncovering Danaher Corp's Intrinsic Value (GuruFocus.com)
Jun-11-24 09:40AM	Is Danaher Corp (NYSE:DHR) the Best Undervalued Stock Pick of Billionaire Paul Tudor Jones? (Insider Monkey)
Jun-09-24 09:00AM	Top Dividend Stocks to Buy in 2024 According to Billionaire Paul Tudor Jones (Insider Monkey)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Option Exercise	58.59	26,318	1,541,972	41,543	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 26 '24	Sale	236.59	26,318	6,226,497	15,225	Nov 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Nov 25 '24	Sale	238.00	8,370	1,992,060	15,225	Nov 27 05:01 PM
Raskas Daniel	Officer	Nov 26 '24	Proposed Sale	236.59	26,318	6,226,496		Nov 26 04:40 PM
Raskas Daniel	Officer	Nov 25 '24	Proposed Sale	238.00	8,370	1,992,060		Nov 25 12:04 PM
Glenstone Foundation	See Remarks	Nov 05 '24	Proposed Sale	247.76	100,000	24,776,000		Nov 05 04:01 PM
Weidemanis Joakim	Former Director	Oct 23 '24	Proposed Sale	254.95	17,659	4,502,216		Oct 23 01:10 PM
Couchara Georgeann	SVP, Human Resources	Aug 26 '24	Sale	268.37	952	255,483	4,212	Aug 27 05:04 PM
Couchara Georgeann	Officer	Aug 26 '24	Proposed Sale	268.37	952	255,483		Aug 26 04:40 PM
Glenstone Foundation	See Remarks	Aug 13 '24	Proposed Sale	267.20	47,937	12,808,766		Aug 13 04:05 PM
Blair Rainer	President & CEO	Jul 31 '24	Sale	280.00	9,007	2,521,960	97,983	Aug 02 05:00 PM
FILLER LINDA	Director	Aug 01 '24	Option Exercise	59.34	3,928	233,088	45,077	Aug 02 05:00 PM
FILLER LINDA	Director	Aug 01 '24	Sale	279.50	3,928	1,097,876	41,149	Aug 02 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Aug 01 '24	Option Exercise	62.85	16,172	1,016,410	45,579	Aug 02 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	Aug 01 '24	Sale	279.84	16,172	4,525,555	29,407	Aug 02 05:00 PM
McGrew Matthew	Officer	Aug 01 '24	Proposed Sale	279.84	16,172	4,525,555		Aug 01 04:28 PM
FILLER LINDA	Director	Aug 01 '24	Proposed Sale	279.50	3,928	1,097,876		Aug 01 12:27 PM
Blair Rainer	Officer	Jul 31 '24	Proposed Sale	280.00	9,007	2,521,960		Jul 31 04:26 PM
Ellis Brian W	Senior Vice President - GC	Jul 25 '24	Sale	275.16	9,600	2,641,536	20,230	Jul 26 05:03 PM
Raskas Daniel	SVP - Corporate Development	Jul 25 '24	Sale	270.51	14,507	3,924,352	23,595	Jul 26 05:03 PM
Zerhouni Elias A.	Director	Jul 15 '24	Option Exercise	52.56	3,289	172,870	37,483	Jul 16 05:01 PM
SCHWIETERS JOHN T	Director	Jul 15 '24	Option Exercise	52.56	3,289	172,870	19,808	Jul 16 05:00 PM
King William	SVP, Strategic Development	May 15 '24	Option Exercise	50.37	12,623	635,821	55,208	May 17 05:10 PM
Blair Rainer	President & CEO	May 16 '24	Sale	265.00	9,005	2,386,325	106,990	May 17 05:08 PM
Blair Rainer	President & CEO	May 14 '24	Option Exercise	59.91	19,085	1,143,435	135,080	May 15 05:00 PM
Blair Rainer	President & CEO	May 14 '24	Sale	255.00	19,085	4,866,675	115,995	May 15 05:00 PM
McGrew Matthew	EVP & Chief Financial Officer	May 10 '24	Option Exercise	61.25	25,174	1,541,794	45,338	May 13 05:01 PM
McGrew Matthew	EVP & Chief Financial Officer	May 10 '24	Sale	253.05	46,377	11,735,856	29,407	May 13 05:01 PM
SPOON ALAN G	Director	May 02 '24	Option Exercise	52.56	3,289	172,870	116,910	May 03 05:03 PM
SPOON ALAN G	Director	May 02 '24	Sale	243.58	708	172,455	116,202	May 03 05:03 PM
Weidemanis Joakim	Executive Vice President	Apr 25 '24	Option Exercise	58.48	22,433	1,311,882	112,845	Apr 26 05:00 PM
Weidemanis Joakim	Executive Vice President	Apr 25 '24	Sale	250.46	22,433	5,618,569	90,412	Apr 26 05:00 PM
Ellis Brian W	Senior Vice President - GC	Apr 24 '24	Sale	250.01	4,000	1,000,040	29,830	Apr 25 05:00 PM
Blair Rainer	President & CEO	Apr 24 '24	Option Exercise	59.91	38,170	2,286,870	154,165	Apr 25 05:00 PM
Blair Rainer	President & CEO	Apr 24 '24	Sale	249.22	47,175	11,756,725	115,995	Apr 25 05:00 PM
Raskas Daniel	SVP - Corporate Development	Feb 26 '24	Option Exercise	58.48	23,757	1,389,309	61,859	Feb 27 05:01 PM
Raskas Daniel	SVP - Corporate Development	Feb 26 '24	Sale	252.00	23,757	5,986,764	38,102	Feb 27 05:01 PM
LOHR WALTER G	Director	Feb 15 '24	Option Exercise	52.56	3,289	172,870	17,418	Feb 16 05:01 PM
LOHR WALTER G	Director	Feb 15 '24	Sale	251.15	3,289	826,032	14,129	Feb 16 05:01 PM
Couchara Georgeann	SVP, Human Resources	Feb 13 '24	Option Exercise	70.71	2,622	185,414	6,022	Feb 14 05:00 PM
Couchara Georgeann	SVP, Human Resources	Feb 13 '24	Sale	242.67	2,622	636,290	4,244	Feb 14 05:00 PM
List Teri	Director	Feb 06 '24	Option Exercise	52.56	3,289	172,870	23,015	Feb 08 05:00 PM
List Teri	Director	Feb 06 '24	Sale	248.32	3,289	816,724	19,726	Feb 08 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DHR

Danaher Corp

Upgrade your FINVIZ experience